|
| ORIGINAL ARTICLE |
|
| Year : 2010 | Volume
: 1
| Issue : 3 | Page : 320-325 |
 |
|
Synthesis and anti-microbial screening of novel schiff bases of 3-amino-2-methyl quinazolin 4-(3H)-one
Govindaraj Saravanan1, Perumal Pannerselvam2, Chinnasamy Rajaram Prakash2
1 Department of Pharmaceutical Chemistry, Medicinal Chemistry Research Laboratory, Bapatla College of Pharmacy, Bapatla - 522 101, Andra Pradesh, India
2 Department of Pharmaceutical Chemistry, C.L. Baid Metha College of Pharmacy, Jyothi Nagar, Thorapakkam, Chennai - 600 096, Tamil Nadu, India
| Date of Web Publication | 10-Nov-2010 |
Correspondence Address:
Govindaraj Saravanan
Medicinal Chemistry Research Laboratory, Bapatla College of Pharmacy, Bapatla - 522 101, Andra Pradesh
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0110-5558.72426
 Abstract | | |
In the present study, novel Schiff bases were synthesized by condensation of 3-amino-2-methyl quinazolin-4-(3H)-ones with different aromatic aldehydes. The 3-amino-2-methyl quinazolin-4-(3H)-one was synthesized from anthranilic acid via the 2-methyl benzoxazin-4-one. The chemical structures of the synthesized compounds were confirmed by means of Infrared (IR), 1 H-NMR, 13 C-NMR, Mass spectral, and Elemental analysis. These compounds were screened for anti-bacterial (Staphylococcus aureus ATCC 9144, Staphylococcus epidermidis ATCC 155, Micrococcus luteus ATCC 4698, Bacillus cereus ATCC 11778, Escherichia coli ATCC 25922, Pseudomonas aeruginosa ATCC 2853, and Klebsiella pneumoniae ATCC 11298)) and anti-fungal (Aspergillus niger ATCC 9029 and Aspergillus fumigatus ATCC 46645) activities, using the paper disk diffusion technique. The minimum inhibitory concentrations (MIC) of the compounds were also determined by the agar streak dilution method. Most of the synthesized compounds exhibited significant anti-bacterial and anti-fungal activities. Among the synthesized compounds, 3-(4-hydroxy benzylideneamino)-2-methyl quinazolin-4(3H)-one 4g and 4c was found to exhibit the highest anti-bacterial activity and 3-(4-hydroxy-3-methoxy benzylideneamino)-2-methyl quinazolin-4(3H)-one 4k exhibited the highest anti-fungal activity. Keywords: 3-amino-2-methyl quinazolin-4-(3H)-one, anti-bacterial, anti-fungal, Schiff base
How to cite this article:
Saravanan G, Pannerselvam P, Prakash CR. Synthesis and anti-microbial screening of novel schiff bases of 3-amino-2-methyl quinazolin 4-(3H)-one. J Adv Pharm Technol Res 2010;1:320-5 |
How to cite this URL:
Saravanan G, Pannerselvam P, Prakash CR. Synthesis and anti-microbial screening of novel schiff bases of 3-amino-2-methyl quinazolin 4-(3H)-one. J Adv Pharm Technol Res [serial online] 2010 [cited 2020 Dec 1];1:320-5. Available from: https://www.japtr.org/text.asp?2010/1/3/320/72426 |
| Introduction | |  |
Quinazolin-4-(3H)-ones have been reported to possess a wide range of biological activities such as anti-microbial. [1],[2],[3],[4],[5] analgesic, [6],[7] anti-inflammatory, [8] anti-convulsant, [9],[10] anti-cancer, [11],[12] anti-tubercular, [13],[14] anti-malarial, [15] and anti-viral [16],[17] activities. Quinazolin 4-(3H)-ones, with substitution at the third position, has been reported to be associated with antimicrobial properties. [18],[19] The various substituents at the third position of quinazolin-4(3H)-one that have been reported, are various substituted phenyl ring moieties, bridged phenyl rings, heterocyclic rings, and the aliphatic system. In addition, in general schiff bases, the presence of pharmacophores like -NO 2 , phenolic OH, -Cl, -CH 3, and -OCH 3 are reported to possess anti-microbial activities. These observations has led to the conception that a novel series of Schiff bases of 3-amino-2-methyl quinazolin-4-(3H)-ones 4a-4l have been synthesized using different aromatic aldehydes by condensation and their chemical structure is confirmed by IR, 1 H-NMR, 13 C-NMR, Mass spectral and Elemental analysis. These compounds have been screened for their anti-bacterial activity against four gram positive bacteria (Staphylococcus aureus ATCC 9144, Staphylococcus epidermidis ATCC 155, Micrococcus luteus ATCC 4698, and Bacillus cereus ATCC 11778), three gram negative bacteria ( Escherichia More Details coli ATCC 25922, Pseudomonas aeruginosa ATCC 2853, and Klebsiella pneumoniae ATCC 11298), and anti-fungal (Aspergillus niger ATCC 9029 and Aspergillus fumigatus ATCC 46645) activities, using the paper disk diffusion technique. The minimum inhibitory concentrations (MIC) of the compounds were also determined by the agar streak dilution method.
| Materials and Methods | | |
The melting points were taken in an open capillary tube and were uncorrected. The IR spectra of the compounds were recorded on an ABB Bomem FT-IR spectrometer MB 104 with KBr pellets. The 1 H (300 MHz) and 13 C-NMR (300 MHz) spectra were recorded on a Bruker 300 NMR spectrometer (with TMS for 1 H and CDCl 3 for 13 C as internal references). Mass spectra were recorded on a Shimadzu GC MS QP 5000. Microanalyses were obtained with an elemental an Analyses system GmbH VarioEL V300 element analyzer. The purity of the compounds was checked by thin layer chromatography (TLC) on pre-coated SiO 2 gel (HF 254 , 200 mesh) aluminium plates (E Merck) using ethyl acetate : n-hexane (20 : 80) and visualized in an ultraviolet (UV) chamber. The reagent grade chemicals were purchased from S.D. Fine-Chem Limited, Mumbai, and Qualigens Fine Chemicals, Mumbai, and purified by either distillation or recrystallization, before use.
Chemistry
In the present study anthranilic acid 1 was treated with acetic anhydride to form 2-methyl benzoxazin-4-one 2, which further reacted with hydrazine hydrate resulting in 3-amino-2-methyl quinazolin-4-(3H)-one 3. Compound 3 was subjected to react with various aromatic aldehydes in the presence of ethanol as a solvent, to form schiff bases.
General Method of Synthesis (4a-4l)
The 3-amino 2-methyl quinazolin-4(3H)-one 3 was prepared according to the reported literature. [18] Equimolar quantities (0.01 mol) of 3-amino 2-methyl quinazolin 4-(3H)-one and aromatic aldehydes were dissolved in 20 ml of ethanol, refluxed for eight hours, and then kept aside for three days. The product that separated out was filtered, dried, and recrystallized from absolute ethanol.
Anti-microbial Screening
The standard strains were procured from the American Type Culture Collection (ATCC), Rockville, USA, and the pathological strains were procured from the Department of Microbiology, CEEAL Analytical Lab, Chennai, India. All test compounds and standard drugs were dissolved in dimethyl formamide for screening the anti-microbial activity. All the synthesized compounds were screened for anti-bacterial and anti-fungal activities by the paper disk diffusion technique. The anti-bacterial activity of the compounds were evaluated against four gram positive bacteria (Staphylococcus aureus ATCC 9144, Staphylococcus epidermidis ATCC 155, Micrococcus luteus ATCC 4698, and Bacillus cereus ATCC 11778) and three gram negative bacteria (Escherichia coli ATCC 25922, Pseudomonas aeruginosa ATCC 2853, and Klebsiella pneumoniae ATCC 11298), using the nutrient agar medium (Hi-Media Laboratories, India). The anti-fungal activities of the synthesized compounds were evaluated against two fungi (Aspergillus niger ATCC 9029 and Aspergillus fumigatus ATCC 46645) using the Sabouraud dextrose agar medium (Hi-Media Laboratories, India). The minimum inhibitory concentrations (MIC) of the compounds were also determined by the agar streak dilution method.
Paper Disk Diffusion Technique
The sterilized [20] (autoclaved at 120°C for 30 min) medium (40 - 50°C) was inoculated (1 ml/100 ml of medium) with the suspension (10 5 cfu/ml) of the microorganism (matched to the McFarland barium sulfate standard) and poured into a petridish to give a depth of 3 - 4 mm. The paper impregnated with the test compounds dissolved in dimethylformamide (100 μg/disk) and was placed on the solidified medium. The plates were pre-incubated for one hour at room temperature and incubated at 37°C for 24 and 48 hours for anti-bacterial and anti-fungal activities, respectively. Ciprofloxacin (100 μg/disk) and Ketoconazole (100 μg/disk) were used as the standards for anti-bacterial and anti-fungal activities, respectively. The observed zone of inhibition is presented in [Table 1].
Minimum Inhibitory Concentration
The Minimum inhibitory concentration (MIC) [21] of the compound was determined by the agar streak dilution method. A stock solution of the synthesized compound (100 μg/ml), in dimethylformamide, was prepared and graded quantities of the test compounds were incorporated in a specified quantity of molten sterile agar (nutrient agar for anti-bacterial activity and Sabouraud dextrose agar medium for anti-fungal activity). A specified quantity of the medium (40 - 50°C) containing the compound was poured into a petridish to give a depth of 3 - 4 mm, and allowed to solidify. A suspension of the microorganism were prepared, to contain approximately 10 5 cfu/ml, and applied on the plates with serially diluted compounds in dimethylformamide, to be tested, and was incubated at 37°C for 24 and 48 hours for bacteria and fungi, respectively. The MIC was considered to be the lowest concentration of the test substance, exhibiting no visible growth of bacteria or fungi on the plate. The observed MIC is presented in [Table 1].
| Results and Discussion | | |
Chemistry
Infrared, 1 H-NMR, 13 C-NMR, Mass spectra, and Elemental analysis were consistent with the assigned structures. The optical activities of the compounds were not checked.
3-Amino 2-methyl Quinazolin-4(3H)-one (3)
Yield: 73%; m.p.141 - 143°C; IR (KBr, cm -1 ): 3030 (Ar-CH), 2927 (CH in CH 3 ), 1716 (C=O), 1464 (C=C), 1332 (N-H). 1 H-NMR (CDCl 3) δ: 7.41-7.82 (m, 4H; C5 ,C 6 ,C 7 ,C 8 ,Ar-H), 1.94 (s, 2H; -NH 2 ), 0.97 (s, 3H; -CH 3 ). 13 C-NMR (CDCl 3) δ: 164.2 (C2 ), 161.7 (C 4 ), 133.6 (C 7 ), 128.2 (C 5 ), 127.6 (C 6 ), 122.3 (C 8 ), 18.9 (-C H 3 ). EI-MS m/z (M+): 175 (Calcd. for C 9 H 9 N 3 O; 175.18). Anal. Calcd. for C 9 H 9 N 3 O; C, 61.70; H, 5.18; N, 23.99. Found: C, 61.65; H, 5.18; N, 23.88 [Figure 1]. | Figure 1 :Synthesis of schiff bases of 3-amino-2-methyl quinazolin- 4(3H)-one
Click here to view |
3-(Benzylideneamino)-2-methyl quinazolin-4-(3H)-one (4a)
Pale yellow crystal; Yield: 80%; m.p. 153 - 155°C; IR (KBr, cm -1 ): 3018 (Ar-CH), 2920 (CH in CH 3 ), 1720 (C=O), 1510 (C=N), 1460 (C=C). 1 H-NMR (CDCl 3) δ: 8.05 (s, 1H; -N=CH -), 7.19-7.88 (m, 9H; C 5 ,C 6 ,C 7 ,C 8 ,C 2' ,C 3' ,C 4' ,C 5' ,C 6' ,Ar-H), 0.86 (s, 3H; C 2 , -CH 3 ). 13 C-NMR (CDCl 3) δ: 164.2 (C2 ), 160.1 (C 4 ), 143.3 (-N=C H-), 133.3 (C 7 ), 131.4 (C 4' ), 129.4 (C 2' and C 6' ), 128.9 (C 3' and C 5' ), 128.6 (C 5 ), 127.1 (C 6 ), 19.8 (-C H 3 ). EI-MS m/z (M+): 263 (Calcd. for C 16 H 13 N 3 O; 263.29). Anal. Calcd. for C 16 H 13 N 3 O; C, 72.99; H, 4.98; N, 15.96. Found: C, 72.95; H, 4.96; N, 15.92.
3-(4-Methoxybenzylideneamino)-2-methyl quinazolin-4-(3H)-one (4b)
Cream solid; Yield: 72%; m.p. 191 - 194°C; IR (KBr, cm -1 ): 3046 (Ar-CH), 2912 (CH in CH 3 ), 1724 (C=O), 1514 (C=N), 1462 (C=C), 1124 (C-O). 1 H-NMR (CDCl 3) δ: 8.07 (s, 1H; -N=CH -), 6.81-7.92 (m, 8H; C 5 ,C 6 ,C 7 ,C 8 ,C 2' ,C 3' ,C 5' ,C 6' ,Ar-H), 3.70 (s, 3H; -OCH 3 ), 0.79 (s, 3H; -CH 3 ). 13 C-NMR (CDCl 3) δ: 163.9 (C2 ), 160.2 (C 4 ),143.2 (-N=C H-), 133.2 (C 7 ), 163.1 (C 4' ), 130.1 (C 2' and C 6' ), 128.6 (C 5 ), 127.3 (C 6 ), 126.2 (C 1' ), 122.2 (C 8 ), 114.3 (C 3' andC 5' ), 55.6 (-OC H 3 ), 20.2 (-C H 3 ). EI-MS m/z (M+): 293 (Calcd. for C 17 H 15 N 3 O 2; 293.31). Anal. Calcd. for C 17 H 15 N 3 O 2; C, 69.61; H, 5.15; N, 14.33. Found: C, 69.58; H, 5.14; N, 14.28.
3-(2-Hydroxybenzylideneamino)-2-methyl quinazolin-4-(3H)-one (4c)
Pale yellow solid; Yield: 66%; m.p. 173 - 175°C; IR (KBr, cm -1 ): 3040 (Ar-CH), 2915 (CH in CH 3 ), 1722 (C=O), 1514 (C=N), 1457 (C=C) 1350,1205 (C-O). 1 H-NMR (CDCl 3) δ: 7.99 (s, 1H; -N=CH -), 6.78-7.88 (m, 8H; C 5 ,C 6 ,C 7 ,C 8 ,C 3' ,C 4' ,C 5' ,C 6' ,Ar-H), 5.41 (s, 1H; Ar-OH ), 0.82 (s, 3H; -CH 3 ). 13 C-NMR (CDCl 3) δ: 163.4 (C2 ), 164.5 (C 2' ) 160.6 (C 4 ), 142.9 (-N=C H-), 133.7 (C 7 ), 132.2 (C 4' ), 130.3 (C 6' ), 128.6 (C 5 ), 127.4 (C 6 ), 122.1 (C 8 ), 121.3 (C 5' ), 118.2 (C 1' ), 116.2 (C 3' ), 20.1 (-C H 3 ). EI-MS m/z (M+): 279 (Calcd. for C 16 H 13 N 3 O 2 ; 279.29). Anal. Calcd. for C 16 H 13 N 3 O 2 ; C, 68.81; H, 4.69; N, 15.05. Found: C, 68.79; H, 4.61; N, 15.01.
3-(4-N,N-dimethylaminobenzylideneamino)-2-methyl quinazolin-4-(3H)-one (4d)
Bright yellow crystal; Yield: 68%; m.p. 187 - 190°C; IR (KBr, cm -1 ): 3032 (Ar-CH), 2920 (CH in CH 3 ), 1720 (C=O), 1518 (C=N), 1453 (C=C). 1 H-NMR (CDCl 3) δ: 8.02 (s, 1H; -N=CH -), 6.75-7.89 (m, 8H; C 5 ,C 6 ,C 7 ,C 8 ,C 2' ,C 3' ,C 5' ,C 6' ,Ar-H), 2.86 (s, 6H; -N-(CH 3 ) 2) , 0.82 (s, 3H; -CH 3 ). 13 C-NMR (CDCl 3) δ: 163.4 (C2 ), 159.2 (C 4 ) 151.2 (C 4' ), 142.2 (-N=C H-), 133.6 (C 7 ), 130.3 (C 2' andC 6' ), 128.6 (C 5 ), 127.6 (C 6 ), 123.2 (C 1' ), 122.3 (C 8 ), 113.8 (C 3' and C 5' ), 55.6 (-OC H 3 ), 20.1 (-C H 3 ). EI-MS m/z (M+): 306 (Calcd. for C 18 H 18 N 4 O; 306.36). Anal. Calcd. for C 18 H 18 N 4 O; C, 70.57; H, 5.92; N, 18.29. Found: C, 70.48; H, 5.94; N, 18.31.
3-(3-Nitrobenzylideneamino)-2-methyl quinazolin-4-(3H)-one (4e)
Cream solid; Yield: 65%; m.p. 190 - 194°C; IR (KBr, cm -1 ): 3017 (Ar-CH), 2922 (CH in CH 3 ), 1715 (C=O), 1524 (C=N), 1522 and 1335 (N=O), 1450 (C=C). 1 H-NMR (CDCl 3) δ: 8.09 (s, 1H; -N=CH -), 7.41-7.92(m, 7H; C 5 ,C 6 ,C 7 ,C 8 ,C 4' ,C 5' ,C 6' ,Ar-H), 0.92 (s, 3H; -CH 3 ). 13 C-NMR (CDCl 3) δ: 163.9 (C2 ), 159.8 (C 4 ), 148.6 (C 3' ), 143.1 (-N=C H-), 134.3 (C 1' ), 135.3 (C 6' ), 133.6 (C 7 ), 129.8 (C 5' ), 128.8 (C 5 ), 127.4 (C 6 ), 124.2 (C 2' ), 123.2 (C 4' ), 122.4 (C 5 ), 20.3 (-C H 3 ). EI-MS m/z (M+): 308 (Calcd. for C 16 H 12 N 4 O 3 ; 308.29). Anal. Calcd. for C 16 H 12 N 4 O 3 ; C, 62.33; H, 3.92; N, 18.17. Found: C, 62.31; H, 3.83; N, 18.14.
3-(4-Methylbenzylideneamino)-2-methyl quinazolin-4-(3H)-one (4f)
Cream crystal; Yield: 76%; m.p. 164 - 166°C; IR (KBr, cm -1 ): 3041 (Ar-CH), 2926 (CH in CH 3 ) 1718 (C=O), 1522 (C=N), 1448 (C=C). 1 H-NMR (CDCl 3) δ: 8.12 (s, 1H; -N=CH -), 7.09-7.81 (m, 8H; C 5 ,C 6 ,C 7 ,C 8 ,C 2' ,C 3' ,C 5' ,C 6' ,Ar-H), 2.36 (s, 3H; -CH 3 ), 0.92 (s, 3H; -CH 3 ). 13 C-NMR (CDCl 3) δ: 164.2 (C2 ), 160.3 (C 4 ), 143.1 (-N=C H-), 133.8 (C 7 ), 130.8 (C 1' ), 129.4 (C 3' and C 5' ), 129.1 (C 2' and C 6' ), 128.6 (C 5 ), 127.4 (C 6 ), 122.6 (C 8 ), 24.3 (-C H 3 ), 20.3 (C H 3 ). EI-MS m/z (M+): 277 (Calcd. for C 17 H 15 N 3 O; 277.32). Anal. Calcd. for C 17 H 15 N 3 O; C, 73.63; H, 5.45; N, 15.15. Found: C, 73.53; H, 5.41; N, 15.14.
3-(4-Hydroxybenzylideneamino)-2-methyl quinazolin-4-(3H)-one (4g)
Pale yellow crystal; Yield: 77%; m.p. 210 - 214°C; IR (KBr, cm -1 ): 3024 (Ar-CH), 2924 (CH in CH 3 ), 1722 (C=O), 1514 (C=N), 1454 (C=C), 1355 and 1208 (C-O). 1 H-NMR (CDCl 3) δ: 7.99 (s, 1H; -N=CH -), 6.82-7.88 (m, 8H; C 5 ,C 6 ,C 7 ,C 8 ,C 2' ,C 3' ,C 5' ,C 6' ,Ar-H), 5.44 (s, 1H; Ar-OH ), 0.88 (s, 3H; -CH 3 ). 13 C-NMR (CDCl 3) δ: 165.1 (C2 ), 160.4 (C 4' ), 159.2 (C 4 ), 144.2 (-N=C H-), 134.2 (C 7 ), 130.5 (C 2' and C 6' ), 129.2 (C 5 ), 127.4 (C 6 ), 122.8 (C 8 ), 115.6 (C 3' and C 5' ), 20.1 (-C H 3 ). EI-MS m/z (M+): 279 (Calcd. for C 16 H 13 N 3 O 2 ; 279.29). Anal. Calcd. for C 16 H 13 N 3 O 2 : C, 68.81; H, 4.69; N, 15.05. Found: C, 68.79; H, 4.64; N, 15.07.
3-(4-Chlorobenzylideneamino)-2-methyl quinazolin-4-(3H)-one (4h)
Pale yellow powder; Yield: 74%; m.p. 259 - 263°C; IR (KBr, cm -1 ): 3036 (Ar-CH), 2932 (CH in CH 3 ), 1726 (C=O), 1520 (C=N), 1446 (C=C), 729 (C-Cl). 1 H-NMR (CDCl 3) δ: 8.12 (s, 1H; -N=CH -), 6.91-7.82 (m, 8H; C 5 ,C 6 ,C 7 ,C 8 ,C 2' ,C 3' ,C 5' ,C 6' ,Ar-H), 0.92 (s, 3H; -CH 3 ). 13 C-NMR (CDCl 3) δ: 163.4 (C2 ), 160.8 (C 4 ), 144.2 (-N=C H-), 136.2 (C 4' ), 133.4 (C 7 ), 132.5 (C 1' ), 130.8 (C 2' and C 6' ), 129.2 (C 3' and C 5' ), 128.6 (C 5 ), 126.9 (C 6 ), 122.4 (C 8 ), 19.8 (-C H 3 ). EI-MS m/z (M+): 297 (Calcd for C 16 H 12 ClN 3 O; 297.73). Anal. Calcd. for C 16 H 12 ClN 3 O; C, 64.54; H, 4.06; N, 14.91. Found: C, 64.50; H, 4.01; N, 14.81.
3-(4-Nitrobenzylideneamino)-2-methyl quinazolin-4-(3H)-one (4i)
Yellow crystal; Yield: 75%; m.p. 222 - 225°C; IR (KBr, cm -1 ): 3048 (Ar-CH), 2926 (CH in CH 3 ), 1715 (C=O), 1524 (C=N), 1518 and 1342 (N=O), 1452(C=C). 1 H-NMR (CDCl 3) δ: 8.12 (s, 1H; -N=CH -), 7.35-7.99 (m, 8H; C 5 ,C 6 ,C 7 ,C 8 ,C 2' ,C 3' ,C 5' ,C 6' ,Ar-H), 0.82 (s, 3H; -CH 3 ). 13 C-NMR (CDCl 3) δ: 165.2 (C2 ), 161.2 (C 4 ), 150.2 (C 4' ), 143.2 (-N=C H-), 140.1 (C 1' ), 134.0 (C 7 ), 129.4 (C 2' and C 6' ), 128.9(C 5 ), 127.6 (C 6 ), 122.6 (C 8 ), 121.2 (C 3' and C 5' ), 0.92 (-C H 3 ). EI-MS m/z (M+): 308 (Calcd. for C 16 H 12 N 4 O 3 ; 308.29). Anal. Calcd. for C 16 H 12 N 4 O 3 ; C, 62.33; H, 3.92; N, 18.17. Found: C, 62.22; H, 3.94; N, 18.21.
3-(3, 4, 5, -Trimethoxybenzylideneamino)-2-methyl quinazolin-4-(3H)-one (4j)
Bright yellow powder; Yield: 70%; m.p. 261 - 264°C; IR (KBr, cm -1 ): 3024 (Ar-CH), 2922 (CH in CH 3 ), 1724 (C=O), 1514 (C=N), 1463 (C=C), 1132 (C-O). 1 H-NMR (CDCl 3) δ: 8.10 (s, 1H; -N=CH -), 7.38-7.92 (m, 4H; C 5 ,C 6 ,C 7 ,C 8 ,Ar-H), 6.61 (s, 1H; C 2' ,Ar-H), 6.64 (s, 1H; C 6' ,Ar-H), 3.82 (s, 9H; [OCH 3 ] 3 ), 0.91 (s, 3H; -CH 3 ). 13 C-NMR (CDCl 3) δ: 164.5 (C2 ), 160.2 (C 4 ), 150.8 (C 3' and C 5' ), 143.3 (-N=C H-), 141.9 (C 4' ), 135.2 (C 7 ), 129.9 (C 5 ), 128.2(C 1' ), 127.6 (C 6 ), 122.6 (C 8 ), 107.1 (C 2' and C 6' ), 56.5 (-OC H 3 ), 21.2 (-C H 3 ). EI-MS m/z (M+): 353 (Calcd for C 19 H 19 N 3 O 4 ; 353.37). Anal. Calcd. for C 19 H 19 N 3 O 4 ; C, 64.58; H, 5.42; N, 11.89. Found: C, 64.49; H, 5.38; N, 11.85.
3-(4-Hydroxy-3-methoxybenzylideneamino)-2-methylquinazolin-4-(3H)-one (4k)
Cream solid; Yield: 65%; m.p. 122 - 124°C; IR (KBr, cm -1 ): 3032 (Ar-CH), 2925 (CH in CH 3 ), 1722 (C=O), 1518 (C=N), 1455 (C=C), 1352 and 1208 (C-O). 1 H-NMR (CDCl 3) δ: 7.92 (s, 1H; -N=CH -), 7.42-7.82 (m, 4H; C 5 ,C 6 ,C 7 ,C 8 ,Ar-H), 7.10 (s, 1H; Ar-H), 6.66-6.69 (d, J=6.7 Hz; C 5' , Ar-H), 7.01-7.05 (d, J=5.8 Hz; C 6' , Ar-H), 5.12 (s, 1H; Ar-OH), 3.90 (s, 3H; -OCH 3 ), 0.92 (s, 3H; -CH 3 ). 13 C-NMR (CDCl 3) δ: 165.1 (C2 ), 161.0 (C 4 ), 151.2 (C 3' ), 148.2 (C 4' ), 143.4 (-N=C H-), 133.6 (C 7 ), 128.6 (C 5 ), 127.6 (C 6 ), 127.4(C 1' ), 122.9 (C 6' ), 122.6 (C 8 ), 56.2 (-OC H 3 ), 20.2 (-C H 3 ). EI-MS m/z (M+): 309 (Calcd. for C 17 H 15 N 3 O 3 ; 309.31). Anal. Calcd. for C 17 H 15 N 3 O 3 ; C, 66.01; H, 4.89; N, 13.58. Found: C, 66.06; H, 4.78; N, 13.62.
3-(3-Phenylallylideneamino)-2-methyl quinazolin-4-(3H)-one (4l)
Lemon yellow crystal; Yield: 75%; m.p. 155 - 157°C; IR (KBr, cm -1 ): 3019 (Ar-CH), 2916 (CH in CH 3 ), 1728 (C=O), 1512 (C=N), 1458 (C=C). 1 H-NMR (CDCl 3) δ: 7.61 (s, 1H; -N=CH -), 7.14-7.88 (m, 9H; C 5 ,C 6 ,C 7 ,C 8 ,C 2' ,C 3' ,C 4' ,C 5', C 6' Ar-H), 6.59-6.62 (d, 1H; J=7.2 Hz; C 6 H 5 -CH =CH-), 5.61-5.63 (d, 1H; J=6.5 Hz; C 6 H 5 -CH=CH -), 0.92 (s, 3H; -CH 3 ). 13 C-NMR (CDCl 3) δ: 164.2 (C2 ), 160.6 (C 4 ), 139.2 (C 6 H 5 -C H=CH-) 137.6 (-N=C H-), 135.2 (C 1' ), 134.6 (C 7 ), 128.8 (C 5 ), 128.6 (C 3' and C 5' ), 128.1 (C 4' ), 127.6 (C 6 ), 126.6 (C2' and C6'), 126.3 (C 6 H 5 -CH=C H-), 20.2 (-C H 3 ). EI-MS m/z (M+): 289(Calcd. for C 18 H 15 N 3 O; 289.33). Anal. Calcd. for C 18 H 15 N 3 O; C, 74.72; H, 5.23; N, 14.52. Found: C, 74.36; H, 5.08; N, 14.38.
Anti-microbial Screening
Most of the synthesized compounds exhibited moderate-to-potent anti-microbial activity against the tested microorganisms. Compounds 4g and 4k were found to possess significant anti-bacterial and anti-fungal activity when compared to the standard drug (Ciprofloxacin and Ketaconazole for anti-bacterial and anti-fungal, respectively). Compounds 4c, 4h, 4i, and 4l displayed moderate anti-microbial activity, whereas, the remaining compounds showed lesser activity. The MIC of the synthesized compounds was screened by the agar streak dilution method. All the synthesized compounds exhibited moderate-to-good anti-bacterial and anti-fungal activity, with an MIC range of 9.2 - 30.6 mg/ml. 3-(4-hydroxy benzylideneamino)-2-methyl quinazolin-4(3H)-one 4g was found to exhibit the highest anti-bacterial activity against S.aureus  (MIC: 9.2 mg/ml), B.cereus (MIC: 9.6 mg/ml), E.coli (MIC: 12.1 mg/ml), and K.pneumoniae (MIC: 10.6 mg/ml). 3-(2-hydroxy benzylideneamino)-2-methyl quinazolin-4(3H)-one 4c was found to exhibit the highest anti-bacterial activity against S.epidermidis (MIC: 9.8 mg/ml), M.luteus (MIC: 11.2 mgml), and P.aeruginosa (MIC: 10.8 mg/ml). 3-(4-hydroxy-3-methoxy benzylideneamino)-2-methyl quinazolin-4(3H)-one 4k exhibited the highest anti-fungal activity against A.niger (MIC: 12.2 mg/ml) and A.fumigatus (MIC: 12.9 mg/ml).The synthesized compounds were active against all the tested microorganisms, with a range of MIC values for S.aureus (9.2 - 25.2mg/ml), S.epidermidis (9.8 - 24.0 mg/ml), M.luteus (11.2 - 27.8 mg/ml), B.cereus (9.6 - 21.2 mg/ml), E.coli (12.1 - 21.9 mg/ml), P.aeruginosa (10.8 - 21.6 mg/ml), K.pneumoniae (10.6 - 23.6 mg/ml), A.niger (12.2 - 29.1 mg/ml), and A.fumigatus (12.9 - 30.6 mg/ml). The potent anti-microbial activity exhibited by 4c, 4g , and 4k may be due to the incorporation of the electron-donating groups like phenolic OH (at either the second or fourth position of the phenyl ring in the 3-substituted quinazolin-4(3H)-ones) and -OCH 3 . The interesting results we observed were that both the electron donating as well as the electron withdrawing groups were found to increase the anti-microbial properties, whereas, the unsubstituted derivatives exhibited a lesser degree of activity. The compound 4g was found to possess anti-bacterial activity almost equivalent to the standard drug, but exhibited considerable anti-fungal activity.
| Conclusion | | |
In conclusion, the present study highlights the importance of aromatic imino substitution at the third position of the quinazolin-4(3H)-one ring features, responsible for the anti-microbial property, and therefore, may serve as a lead molecule to obtain clinically useful, novel entities, in the new millennium.
| References | | |
| 1. | Trivedi PB, Undavia NK, Dave AM, Bhatt KN, Desai NC. Synthesis and anti-microbial activity of some heterocyclic compounds. Indian J Chem Br 1993;32:497-500. 
|
| 2. | Kant P. Synthesis and anti-microbial activities of some new 2-substituted 3(1'-aryl-4'-nitrophenyl imidazol-5'-yl) amino quinazolin-4-ones. Indian J Heterocycl Chem 2006;15:221-4.
|
| 3. | Srivastava MK, Mishra B, Nizamuddin. Pharmacological studies of some 2-methyl 3-(arylthio carbamido) quinazol-4-ones and 2-methyl 3(aryliden carboxamido) quinazol-4-ones. Indian J Chem Br 2001;40:342-4.
|
| 4. | Mishra P, Panneerselvam P, Jain S. A few 2-methyl quinazolin-4(3H)-ones as anti-microbial agents. J Indian Chem Soc 1995;72:559-60.
|
| 5. | Jatav V, Jain SK, Kashaw SK, Mishra P. Synthesis and anti-microbial activity of novel 2-methyl 3(1',3',4'-thiadiazolyl) 4(3H)-quinazolinones. Indian J Pharm Sci 2006;68:360-3.
 |
| 6. | Alagarsamy V, Rajasolomon V, Vanikavitha G, Paluchamy V, Ravi Chandran M, Arnold Sujin A, et al. Synthesis, analgesic, anti-inflammatory and anti-bacterial activities of some novel 2-phenyl 3-substituted quinazolin-4(3H)-ones. Biol Pharm Bull 2002;25:1432-5.
|
| 7. | Pannerselvam P, Pradeepchandran RV, Sridhar SK. Synthesis, characterization and biological activities of novel 2-methyl quinazolin-4(3H)-ones. Indian J Pharm Sci 2003;65:268-73.
|
| 8. | Rani P, Archana, Srivastava VK, Kumar A. Synthesis and anti-inflammatory activity of some new 2,3-disubstituted 6-monosubstituted quinazolin-4(3H)-ones. Indian J Chem Br 2002;41:2642-6.
|
| 9. | Archana, Srivastava VK, Chandra R, Kumar A. Synthesis of potential quinazolinonyl pyrazolines and quinazolinonyl isoxazolines as anticonvulsant agents. Indian J Chem Br 2002;41:2371-5.
|
| 10. | Alagarsamy V, Thangathirupathi A, Mandal SC, Rajasekaran S, Vijayakumar S, Revathi R, et al. Pharmacological evaluation of 2-substituted (1,3,4)-thiadiazolo quinazolines. Indian J Pharm Sci 2006;68:108-11.
|
| 11. | El-Hiti GA, Abdel-Megeed MF, Zied TM. Synthesis and reaction of some 3-aryl 2-thioxo quinazolin-4(3H)-ones. Indian J Chem Br 2002;41:1519-22.
|
| 12. | Murgan V, Thomas CC, Rama Sarma GV, Kumar EP. Synthesis of 2-substituted quinazolin-4(3H)-ones as a new class of anticancer agents. Indian J Pharm Sci 2003;65:386-9.
|
| 13. | Pattan SR, Krishna Reddy VV, Manvi FV, Desai BG, Bhat AR. Synthesis of N-3[4(4-chlorophenyl thiazol-2-yl) 2-aminomethyl] quinazolin-4(3H)-one and their derivatives for antitubercular activity. Indian J Chem Br 2006;45:1778-81.
|
| 14. | Nandy P, Vishalakshi MT, Bhat AR. Synthesis and antitubercular activity of mannich bases of 2-methyl 3H-quinazolin-4-ones. Indian J Heterocycl Chem 2006;15:293-4.
|
| 15. | Lakhan R, Singh OP, Singh RL. Studies in 4(3H)-quinazolinone derivatives as antimalarial. J Indian Chem Soc 1987;64:316-8.
|
| 16. | Bishnoi A, Saxena R, Srivastava K, Joshi MN, Bajpai SK. Synthesis and biological activity of oxo/thionotriazolo isoquinolinyl quinazolones. Indian J Heterocycl Chem 2006;15:307-8.
|
| 17. | Pandey VK, Mukesh, Tandon M. Synthesis and antiviral activity of quinazolinyl syndnones. Indian J Heterocycl Chem 2006;15:399-400.
|
| 18. | Alagarsamy V, Rajasolomon V, Meena R, Ramseshu VK. Synthesis, analgesic, anti-inflammatory and anti-bacterial activities of some novel 2-butyl 3-substituted quinazolin-4(3H)-ones. Biol Pharm Bull 2005;28:1091-4.
|
| 19. | Alagarsamy V, Muruganantham G, Venkateshaperumal R. Synthesis, analgesic, anti-inflammatory and anti-bacterial activities of some novel 2-methyl 3-substituted quinazolin-4(3H)-ones. Biol Pharm Bull 2003;26:1711-4.
|
| 20. | Gillespie SH. Medical Microbiology-Illustrated. United Kingdom: Butterworth Heinemann Ltd; 1994. p. 234-47.
|
| 21. | Hawkey PM, Lewis DA. Medical bacteriology: A practical approach. United Kingdom: Oxford university press; 1994. p. 181-94.
|
[Figure 1]
[Table 1]
| This article has been cited by | | 1 |
A Natural Quinazoline Derivative from Marine Sponge Hyrtios erectus Induces Apoptosis of Breast Cancer Cells via ROS Production and Intrinsic or Extrinsic Apoptosis Pathways |
|
| Arun Kumar De,Ramachandran Muthiyan,Samiran Mondal,Nilkamal Mahanta,Debasis Bhattacharya,Perumal Ponraj,Kangayan Muniswamy,Anandamoy Kundu,Madhu Sudhan Kundu,Jai Sunder,Dhanasekar Karunakaran,Asit Kumar Bera,Sibnarayan Dam Roy,Dhruba Malakar | | Marine Drugs. 2019; 17(12): 658 | | [Pubmed] | [DOI] | | | 2 |
Synthesis, characterization, spectroscopic studies and biological evaluation of Schiff bases derived from 1–hydroxy-2-acetonapthanone |
|
| B.T. Vhanale,N.J. Deshmukh,A.T. Shinde | | Heliyon. 2019; 5(11): e02774 | | [Pubmed] | [DOI] | | | 3 |
Novel and highly effective composites of silver and zinc oxide nanoparticles with some transition metal complexes against different microorganisms |
|
| A.S. Orabi,K.M. Abou El-Nour,M.F. Youssef,H.A. Salem | | Arabian Journal of Chemistry. 2018; | | [Pubmed] | [DOI] | | | 4 |
An efficient protocol for the synthesis of highly sensitive indole imines utilizing green chemistry: optimization of reaction conditions |
|
| Bushra Nisar,Syeda Laila Rubab,Abdul Rauf Raza,Sobia Tariq,Ayesha Sultan,Muhammad Nawaz Tahir | | Molecular Diversity. 2018; | | [Pubmed] | [DOI] | | | 5 |
New potential antitumor quinazolinones derived from dynamic 2-undecyl benzoxazinone: Synthesis and cytotoxic evaluation |
|
| Mohamed H. Hekal,Fatma S. M. Abu El-Azm | | Synthetic Communications. 2018; 48(18): 2391 | | [Pubmed] | [DOI] | | | 6 |
<i>a</i>-Glucosidase Inhibition by New Schiff Base Complexes of Zn(II) |
|
| Rie Miyazaki,Hiroyuki Yasui,Yutaka Yoshikawa | | Open Journal of Inorganic Chemistry. 2016; 06(02): 114 | | [Pubmed] | [DOI] | | | 7 |
Transition metal complexes of symmetrical and asymmetrical Schiff bases as antibacterial, antifungal, antioxidant, and anticancer agents: progress and prospects |
|
| Ikechukwu P. Ejidike,Peter A. Ajibade | | Reviews in Inorganic Chemistry. 2015; 35(4) | | [Pubmed] | [DOI] | | | 8 |
New tetradentate Schiff bases of 2-amino-3,5-dibromobenzaldehyde with aliphatic diamines and their metal complexes: Synthesis, characterization and thermal stability |
|
| Khosro Mohammadi,Seyyedeh Sedigheh Azad,Ameneh Amoozegar | | Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy. 2015; | | [Pubmed] | [DOI] | | | 9 |
Synthesis of Quinazolinone Based Schiff Bases as Potential Anti-inflammatory and Analgesic Agents |
|
| Rashmi Arora,N.S. Gill,Ashish Kapoor | | Journal of Pharmacy and Allied Health Sciences. 2014; 4(1): 15 | | [Pubmed] | [DOI] | | | 10 |
Schiff Bases: A Short Survey on an Evergreen Chemistry Tool |
|
| Wenling Qin,Sha Long,Mauro Panunzio,Stefano Biondi | | Molecules. 2013; 18(10): 12264 | | [Pubmed] | [DOI] | | | 11 |
Synthesis and Bioactivity Evaluation of Novel Arylimines Containing a 3-Aminoethyl-2-[(p-trifluoromethoxy)anilino]-4(3H)-quinazolinone Moiety |
|
| Xiang Wang,Pei Li,Zhining Li,Juan Yin,Ming He,Wei Xue,Zhiwei Chen,Baoan Song | | Journal of Agricultural and Food Chemistry. 2013; 61(40): 9575 | | [Pubmed] | [DOI] | | | 12 |
Antipathogenic effects of structurally-related Schiff base derivatives: Structure–activity relationship |
|
| Soleiman Hisaindee,Leena Al-Kaabi,Suad Ajeb,Yaser Torky,Rabah Iratni,Na’il Saleh,Synan F. AbuQamar | | Arabian Journal of Chemistry. 2013; | | [Pubmed] | [DOI] | | | 13 |
Synthesis, characterization and antimicrobial evaluation of some schiff bases and their thiazolidinone products |
|
| Gebretekle, D. and Tadesse, A. and Upadhyay, R.K. and Dekebo, A. | | Oriental Journal of Chemistry. 2012; 28(4): 1791-1796 | | [Pubmed] | | | 14 |
Synthesis, spectral characterizations and antimicrobial activity of some Schiff bases of 4-chloro-2-aminophenol |
|
| Cinarli, A. and Gürbüz, D. and Tavman, A. and Seher Birteksöz, A. | | Bulletin of the Chemical Society of Ethiopia. 2011; 25(3): 407-417 | | [Pubmed] | |
|
 |
|
|
|
